Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 5;61(5):1760-1768.
doi: 10.1093/rheumatology/keac115.

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

Affiliations

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

Alexander G S Oldroyd et al. Rheumatology (Oxford). .
No abstract available

Keywords: DMARDs; adolescent rheumatology; immunosuppressants; muscle; myositis; paediatric/juvenile rheumatology.

PubMed Disclaimer

References

    1. Meyer A, Meyer N, Schaeffer M. et al. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology 2021;54:50–63. - PubMed
    1. Parker MJS, Oldroyd A, Roberts ME. et al. Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: a 10-year epidemiological study. Rheumatol Adv Pract 2018;2:rky035. - PMC - PubMed
    1. Scottish Intercollegiate Guidelines Network. SIGN 50 – A Guideline Developer’s Handbook. 2011. https://www.sign.ac.uk/assets/sign50_2011.pdf (10 February 2022, date last accessed).
    1. Tomasova Studynkova J, Mann H, Jarosova K. et al. OP0289 a prospective, randomized, open-label, assessor-blind, multicenter study of efficacy and safety of combined treatment of methotrexate + glucocorticoids versus glucocorticoids alone in patients with polymyositis and dermatomyositis (prometheus trial). Ann Rheum Dis 2014;73:171.
    1. Ueno KI, Shimojima Y, Kishida D, Sekijima Y, Ikeda SI.. Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis. Int J Rheum Dis 2016;19:1322–30. - PubMed

Publication types